Skip to main content
. 2025 Feb 11;5(1):e35. doi: 10.1017/ash.2025.17

Table 2.

Multivariate predictors of the number of tests per patient, squared root cost of tests per patient, empiric days of therapy, and log-transformed length of stay

Number of tests per patient (negative binomial) Squared root- cost of tests per patient (linear) Empiric DOT (zero-inflated model) Log Length of Stay (linear)
Predictors Incidence Rate Ratios CI P Estimates CI P Incidence Rate Ratios CI P Estimates CI P
(Intercept) 3.96 2.54 – 6.17 <0.001 16.11 7.25 – 24.97 <0.001 6.26 1.16 – 33.80 0.033 1.31 0.45 – 2.18 0.003
Study Period [Post Intervention] 0.83 0.69 – 1.01 0.063 3.46 –0.25 – 7.17 0.068 0.55 0.26 – 1.13 0.102 0.14 –0.23 – 0.50 0.461
Age (Years) 1.00 0.99 – 1.00 0.714 0.05 –0.06 – 0.16 0.359 0.99 0.97 – 1.01 0.467 0.00 –0.01 – 0.01 0.762
Gender [Male] 1.16 0.96 – 1.40 0.118 1.30 –2.36 – 4.97 0.485 0.67 0.33 – 1.36 0.263 0.38 0.03 – 0.74 0.035
Race [Others vs. White] 1.00 0.82 – 1.22 0.997 0.28 –3.52 – 4.08 0.885 0.80 0.38 – 1.67 0.556 0.04 –0.33 – 0.41 0.832
Location [Floor vs. ED] 1.01 0.70 – 1.47 0.943 7.37 –0.04 – 14.77 0.051 3.50 0.90 – 13.70 0.072 –0.18 –0.90 – 0.54 0.625
Location [ICU vs. ED] 0.89 0.60 – 1.32 0.552 7.01 –0.86 – 14.88 0.081 0.82 0.20 – 3.28 0.777 0.93 0.16 – 1.70 0.018
Diabetes 1.96 1.08 – 3.61 0.028 5.23 –8.25 – 18.70 0.445 0.42 0.04 – 3.99 0.449 –0.11 –1.42 – 1.20 0.869
Transplant 1.93 1.39 – 2.70 <0.001 9.86 2.63 – 17.09 0.008 0.79 0.21 – 2.90 0.720 0.79 0.08 – 1.49 0.028
ESRD 1.34 0.83 – 2.17 0.240 6.01 –4.26 – 16.28 0.250 0.73 0.11 – 4.73 0.745 0.35 –0.65 – 1.35 0.495
VP Shunt 0.62 0.38 – 0.99 0.048 –16.36 –24.67 – –8.05 <0.001 0.64 0.14 – 2.95 0.568 0.12 –0.69 – 0.93 0.773
Encephalitis 1.75 0.86 – 3.61 0.119 6.94 –8.52 – 22.40 0.377 0.10 0.01 – 1.48 0.094 –1.44 –2.95 – 0.07 0.061
HIV 1.62 1.17 – 2.24 0.004 12.05 4.96 – 19.14 0.001 0.26 0.08 – 0.86 0.027 –0.11 –0.80 – 0.58 0.757
Observations 231 231 231 231
R2 Nagelkerke 0.275 0.185/0.140 0.619/0.596 0.211/0.168